Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat 06/06/14 Boston
Clovis Shares Tumble as Analysts Give Edge to Lung-Cancer Rival 06/04/14 Boulder/Denver
Q2 Review: Top San Francisco Stories from April, May, and June 07/01/13 San Francisco
Clovis Oncology Boosts Public Offering to $240M After Stock Booms 06/12/13 Boulder/Denver
Clovis Oncology to Raise $170M as Stock Price Booms Following ASCO 06/10/13 Boulder/Denver
East Coast Life Sciences Roundup: ASCO, Follica, Aveo, & More 06/07/13 Boston
Celgene Drug Keeps Pancreatic Patients Alive an Extra Two Months in Trial 01/23/13 New York
Bristol-Myers Wrangles Top Academics to Study Immunity in Cancer 06/07/12 New York
FDA Rejects Ariad/Merck Sarcoma Pill, Wall Street Unfazed 06/06/12 New York
Bayer Oncology Dubs ASCO “Turning Point” for Cancer Efforts 06/06/12 New York
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail 06/03/12 San Francisco
Merck Oncology Chief Heads to ASCO With High Hopes for New Drugs 05/31/12 New York
Genentech, Roche Find New Balance Three Years Post-Merger 05/29/12 San Francisco
The 2012 New York ASCO Checklist 05/24/12 New York
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
Ariad Brings Third Cancer Drug Into Human Trials 09/22/11 Boston
Aura Adds $4.5M, Syndax To Present Breast Cancer Results at ASCO, PKE Buys Caliper, & More Boston-Area Life Sciences News 09/09/11 Boston
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial 09/06/11 Boston
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News 06/10/11 Boston
Stemline Makes Headway Against Cancer Stem Cells And Proves Value of Virtual Model 06/08/11 New York
Ariad and Merck Say Sarcoma Drug Improves Survival 06/06/11 Boston
Ariad and Infinity to Reveal Data at ASCO, Excelimmune Gets $10.5M, Hologic Buys TCT, & More Boston-Area Life Sciences News 06/03/11 Boston
New York Area Companies Head to ASCO With High Hopes For Future Cancer Blockbusters 06/01/11 New York
Cyclacel Looks to ASCO as Showcase for Potent Cancer-Fighting Cocktail 05/31/11 New York
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News 05/27/11 Boston
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence 05/26/11 Boston
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
Prepared Response Raises $6.3M, Cell Therapeutics Loses Debt, RealNetworks Gets Into Netbooks, & More Seattle-Area Deals News 06/09/09 Seattle
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data 05/15/09 Boston
Page 1 of 2 next page »